Recurrent Astrocytoma, IDH-Mutant, Grade 4

specific

The reemergence of astrocytoma, IDH-mutant, grade 3 after a period of remission.

18

Centers

18

Active Trials

Cancer Funding

Top Centers for Recurrent Astrocytoma, IDH-Mutant, Grade 4(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
52.8
2
NCI Comprehensive
Active Research Program
52.8
3
NCI Comprehensive
Active Research Program
52.8
4
NCI Comprehensive
Active Research Program
52.8
5
NCI Comprehensive
Active Research Program
52.8
6
NCI Comprehensive
Active Research Program
52.8
7
NCI Comprehensive
Active Research Program
52.8
852.8
9
NCI Comprehensive
Active Research Program
52.8
10
NCI Comprehensive
Active Research Program
52.8
11
NCI Comprehensive
Active Research Program
52.8
12
NCI Comprehensive
Active Research Program
52.8
13
NCI Clinical
Active Research Program
52.8
14
NCI Comprehensive
Active Research Program
52.8
15
NCI Comprehensive
Active Research Program
52.8
16
Active Research Program
52.8
17
Active Research Program
52.8
18
Active Research Program
52.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →